AAAAAA
Results:
1-16
|
Results: 16
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease
Authors:
Bonfante, V
Viviani, S
Devizzi, L
Di Russo, A
Di Nicola, M
Magni, M
Matteucci, P
Grisanti, S
Valagussa, P
Bonadonna, G
Gianni, AM
Citation: V. Bonfante et al., High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease, EUR J HAEMA, 66, 2001, pp. 51-55
Authors:
Tarella, C
Zallio, F
Caracciolo, D
Cuttica, A
Corradini, P
Gavarotti, P
Ladetto, M
Podio, V
Sargiotto, A
Rossi, G
Gianni, AM
Pileri, A
Citation: C. Tarella et al., High-dose mitoxantrone plus melphalan (MITO/L-PAM) as conditioning regimensupported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity, LEUKEMIA, 15(2), 2001, pp. 256-263
Authors:
Cortelazzo, S
Rambaldi, A
Rossi, A
Oldani, E
Ghielmin, M
Benedetti, F
Tarella, C
Zaglio, F
Vitolo, U
Di Nicola, M
Pogliani, E
Cavalli, F
Gianni, AM
Barbui, T
Citation: S. Cortelazzo et al., Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma, BR J HAEM, 114(2), 2001, pp. 333-341
Authors:
Gianni, AM
Piccart, MJ
Citation: Am. Gianni et Mj. Piccart, Optimising chemotherapy dose density and dose intensity: new strategies toimprove outcomes in adjuvant therapy for breast cancer - Introduction, EUR J CANC, 36, 2000, pp. S1-S3
Authors:
Di Nicola, M
Carlo-Stella, C
Milanesi, M
Magni, M
Longoni, P
Mortarini, R
Anichini, A
Tomanin, R
Scarpa, M
Gianni, AM
Citation: M. Di Nicola et al., Large-scale feasibility of gene transduction into human CD34(+) cell-derived dendritic cells by adenoviral/polycation complex, BR J HAEM, 111(1), 2000, pp. 344-350
Authors:
Magni, M
Di Nicola, M
Devizzi, L
Matteucci, P
Lombardi, F
Gandola, L
Ravagnani, F
Giardini, R
Dastoli, G
Tarella, C
Pileri, A
Bonadonna, G
Gianni, AM
Citation: M. Magni et al., Successful in vivo purging of CD34-containing peripheral blood harvests inmantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion, BLOOD, 96(3), 2000, pp. 864-869
Authors:
Di Nicola, M
Milanesi, M
Magni, M
Bregni, M
Carlo-Stella, C
Longoni, P
Tomanin, R
Ravagnani, F
Scarpa, M
Jordan, C
Gianni, AM
Citation: M. Di Nicola et al., Recombinant adenoviral vector-LipofectAMINE complex for gene transduction into human T lymphocytes, HUM GENE TH, 10(11), 1999, pp. 1875-1884
Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF
Authors:
Siena, S
Bregni, M
Gianni, AM
Citation: S. Siena et al., Mobilization of peripheral blood progenitor cells for autografting: chemotherapy and G-CSF or GM-CSF, BAIL CLIN H, 12(1-2), 1999, pp. 27-39
Authors:
Boccadoro, M
Tarella, C
Palumbo, A
Argentino, C
Triolo, S
Dominietto, A
Callea, V
Lauta, VM
Molica, S
Musto, P
Marmont, F
Gianni, AM
Pileri, A
Citation: M. Boccadoro et al., An analysis of which subgroups of multiple myeloma patients, divided according to beta(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy, HAEMATOLOG, 84(10), 1999, pp. 905-910
Authors:
Di Nicola, M
Longoni, P
Magni, AM
Gianni, AM
Citation: M. Di Nicola et al., The influence of interleukin (IL)-4 and IL-13 on human dendritic cell differentiation from CD34(+) progenitor cells: the importance of the source of serum, EXP HEMATOL, 27(2), 1999, pp. 386-387
Authors:
Perfetti, V
Ubbiali, P
Magni, M
Vignarelli, MC
Casarini, S
Matteucci, P
Gianni, AM
Merlini, G
Citation: V. Perfetti et al., Cells with clonal light chains are present in peripheral blood at diagnosis and in apheretic stem cell harvests of primary amyloidosis, BONE MAR TR, 23(4), 1999, pp. 323-327
Authors:
Ravagnani, F
Siena, S
De Reys, S
Di Nicola, M
Notti, P
Giardini, R
Bregni, M
Matteucci, P
Gianni, AM
Pellegris, G
Citation: F. Ravagnani et al., Improved collection of mobilized CD34+ hematopoietic progenitor cells by anovel automated leukapheresis system, TRANSFUSION, 39(1), 1999, pp. 48-55
Authors:
Anichini, A
Molla, A
Mortarini, R
Tragni, G
Bersani, I
Di Nicola, M
Gianni, AM
Pilotti, S
Dunbar, R
Cerundolo, V
Parmiani, G
Citation: A. Anichini et al., An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions, J EXP MED, 190(5), 1999, pp. 651-667
Authors:
Di Nicola, M
Anichini, A
Mortarini, R
Bregni, M
Parmiani, G
Gianni, AM
Citation: M. Di Nicola et al., Human dendritic cells: natural adjuvants in antitumor immunotherapy, CYTOK CELL, 4(4), 1998, pp. 265-273
Authors:
Tagliabue, E
Pilotti, S
Gianni, AM
Menard, S
Colnaghi, MI
Citation: E. Tagliabue et al., Target molecules for immunotherapy of inflammatory breast carcinomas, EUR J CANC, 34(12), 1998, pp. 1982-1983
Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors
Authors:
Di Nicola, M
Siena, S
Bregni, M
Longoni, P
Magni, M
Milanesi, M
Matteucci, P
Mortarini, R
Anichini, A
Parmiani, G
Drexler, I
Erfle, V
Sutter, G
Gianni, AM
Citation: M. Di Nicola et al., Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors, CANC GENE T, 5(6), 1998, pp. 350-356
Risultati:
1-16
|